Representation of race and ethnicity among cancer survivors in trials of cognitive behavioral therapy for insomnia (CBT-I): A systematic review.
Representation of race and ethnicity among cancer survivors in trials of cognitive behavioral therapy for insomnia (CBT-I): A systematic review.
复制标题
失眠认知行为疗法（CBT-I）试验中癌症幸存者的种族和民族代表性：系统评价。
DOI：
10.1007/s00520-023-08207-2
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Hall,DanielL
中科院分区：
文献类型：
--
作者：
Li,Raissa;Ma,Yan;ArditteHall,KimberlyA;Johnson,Caetlin;Philpotts,LisaL;Perez,GiselleK;Park,ElyseR;Hall,DanielL
对于癌症幸存者来说，失眠是非常普遍和虚弱的。虽然失眠症的认知行为疗法（CBT-I）被认为是金标准治疗，但目前尚不清楚治疗的益处是否适用于美国的种族和少数民族。这一系统的审查特点的种族和民族多样性之间的癌症幸存者在CBT-I临床试验的代表性，并提供建议，研究在睡眠/癌症survivorship.MethodsLiterature搜索进行了5个电子数据库（PubMed，科克伦图书馆通过奥维德，PsycINFO通过奥维德，Embase，Web的科学核心收集）使用的概念CBT，失眠，癌症幸存者。CBT-I干预的细节，样本种族人口统计学，以及作者是否明确分析了种族和民族的信息recorded.ResultsA共检索到1673引文，967引文上传到Covidence。其中，135篇文章进行了全文审查，13项研究被纳入。11/13项试验（84.6%）报告了人种和种族。在报告人种和种族的试验中，8/11（72.7%）项试验由≥ 85%的非西班牙裔白色样本组成。在明确分析种族和民族的试验中，CBT-I是更有效的癌症幸存者谁是白色和受过高等教育的，和非白人癌症幸存者不太可能有私人保险和能力参加临床试验。ConclusionNon-Hispanic白色癌症幸存者是过多的CBT-I试验，最好的治疗失眠。少数种族和族裔代表性不足可能会造成获取和吸收方面的障碍。建议包括持续努力扩大CBT-I癌症幸存者临床试验的多样性。
PurposeFor cancer survivors, insomnia is highly prevalent and debilitating. Although cognitive behavioral therapy for insomnia (CBT-I) is recognized as a gold standard treatment, it is unclear whether benefits of treatment generalize to racial and ethnic minorities in the USA. This systematic review characterizes the representation of racial and ethnic diversity among cancer survivors in CBT-I clinical trials and provides recommendations for research in sleep/cancer survivorship.MethodsLiterature searches were conducted in five electronic databases (PubMed, Cochrane Library via Ovid, PsycINFO via Ovid, Embase, Web of Science Core Collection) using concepts of CBT, insomnia, and cancer survivors. Information about CBT-I intervention details, sample racial demographics, and whether authors explicitly analyzed race and ethnicity were recorded.ResultsA total of 1673 citations were retrieved, and 967 citations were uploaded to Covidence. Of these, 135 articles went through full-text review and 13 studies were included. Race and ethnicity were reported in 11/13 trials (84.6%). Of those reporting race and ethnicity, 8/11 (72.7%) trials were comprised of samples that were ≥ 85% non-Hispanic White. Among the trials that explicitly analyzed race and ethnicity, CBT-I was more effective among cancer survivors who were White and highly educated, and non-White cancer survivors were less likely to have private insurance and ability to participate in clinical trials.ConclusionNon-Hispanic White cancer survivors are overrepresented in CBT-I trials, the best available treatment for insomnia. Underrepresentation of racial and ethnic minorities likely contributes to barriers in access and uptake. Recommendations include implementing sustained efforts to expand diversity in CBT-I clinical trials for cancer survivors.